Summit Research Says CyberArk's Cutting Edge Technology Is Appealing To Many Businesses, Says Cisco And IBM Would Also Have Use For CyberArk Assets, Expects Consolidation In Sector And Believes CyberArk Could Go For A PremiumEddie Staley , Benzinga Staff Writer
CNA Finance 6/24/15 Synergy Pharmaceuticals (SGYP) Stock Climbs Back Up
Moving forward, I’m expecting to see positive news from Synergy Pharmaceuticals in both the short and long term view. Short Term – In the short run, get ready for more big gains, Synergy Pharmaceuticals got plenty of potential for upside growth. Long Term – In the long run, I’m also expecting to see incredibly bullish activity. First off, I’m very impressed with the results of plecanatide thus far; and think that the drug will become even more impressiveafter the release of data from the study that was initiated yesterday.Also, Synergy Pharmaceuticals has demonstrated the fact that they have strong management and a strong core team time and time again
want to be in for that !
Nice uote From MD Anderson President
MD Anderson President Ron DePinho, M.D., said:
Genetically engineering our patients’ immune-system T cells to efficiently attack and destroy cancer cells represents one of the most exciting approaches with curative potential in oncology today. We believe coupling MD Anderson’s unique CAR T cell approach with the powerful technologies of ZIOPHARM and Intrexon will allow us to build T cells that hit cancer harder, with greater precision, under tighter control and with potentially fewer side effects for patients. This agreement ranks as one of MD Anderson’s most substantial collaborations and will provide significant resources to fuel its mission of Making Cancer History
CyberArk Files For Secondary Offering After Strong Q1
BY GILLIAN RICH, INVESTOR'S BUSINESS DAILY
6-8-15 08:54 AM ET
CyberArk Software (NASDAQ:CYBR) said Friday it filed for a follow-on stock offering.
The cybersecurity company filed a registration statement with the Securities and Exchange Commission for the secondary offering. The majority of the shares will be sold by current shareholders with $50 million in shares to be sold by CyberArk. The total number of shares to be sold hasn't been decided yet.
that is correct View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original FormatView Filing in XBRL F-1 05/29/15